Boston Scientific (BSX) Net Income (2009 - 2026)

Boston Scientific (BSX) has 18 years of Net Income data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Net Income rose 99.11% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $3.6 billion (up 75.75% YoY), and the FY2025 full-year result was $2.9 billion, up 56.66% from the prior year.
• Net Income improved to $1.3 billion in Q1 2026, from $670.0 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $1.3 billion in Q1 2026 to a low of $111.0 million in Q1 2022.
• A 5-year average of $492.3 million and a median of $493.0 million in 2024 frame the typical range for Net Income.
• Across the five-year window, Net Income sank 67.45% in 2022 and surged 257.45% in 2023, its largest moves.
• Tracing BSX's Net Income over 5 years: stood at $141.0 million in 2022, then surged by 257.45% to $504.0 million in 2023, then gained by 11.51% to $562.0 million in 2024, then climbed by 19.22% to $670.0 million in 2025, then jumped by 99.7% to $1.3 billion in 2026.
• Business Quant data shows BSX's Net Income at $1.3 billion in Q1 2026, $670.0 million in Q4 2025, and $756.0 million in Q3 2025.